Mercury (element): Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|indicationType=treatment | |indicationType=treatment | ||
|indication=FOR THE TEMPORARY RELIEF OF DIZZINESS,FEELING DISCOURAGED, DEPRESSION, PAINFUL DRYNESS OF THROAT | |indication=FOR THE TEMPORARY RELIEF OF DIZZINESS,FEELING DISCOURAGED, DEPRESSION, PAINFUL DRYNESS OF THROAT | ||
|adverseReactions=hypersensitivity and nephrotoxicity | |adverseReactions=[[hypersensitivity]] and [[nephrotoxicity]] | ||
|blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span> | |blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span> | ||
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i> | |blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i> | ||
Line 16: | Line 16: | ||
<!--FDA-Labeled Indications and Dosage (Adult)--> | <!--FDA-Labeled Indications and Dosage (Adult)--> | ||
|fdaLIADAdult=* FOR THE TEMPORARY RELIEF OF DIZZINESS,FEELING DISCOURAGED, DEPRESSION, PAINFUL DRYNESS OF THROAT. | |fdaLIADAdult=* FOR THE TEMPORARY RELIEF OF DIZZINESS,FEELING DISCOURAGED, DEPRESSION, PAINFUL DRYNESS OF THROAT. | ||
|offLabelAdultGuideSupport= | |offLabelAdultGuideSupport= | ||
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | ||
<!--Non–Guideline-Supported Use (Adult)--> | <!--Non–Guideline-Supported Use (Adult)--> | ||
|offLabelAdultNoGuideSupport= | |offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | ||
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | |||
<!--Pediatric Indications and Dosage--> | <!--Pediatric Indications and Dosage--> | ||
<!--FDA-Labeled Indications and Dosage (Pediatric)--> | <!--FDA-Labeled Indications and Dosage (Pediatric)--> | ||
|fdaLIADPed= | |fdaLIADPed=There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients. | ||
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients. | |||
<!--Off-Label Use and Dosage (Pediatric)--> | <!--Off-Label Use and Dosage (Pediatric)--> | ||
<!--Guideline-Supported Use (Pediatric)--> | <!--Guideline-Supported Use (Pediatric)--> | ||
|offLabelPedGuideSupport= | |offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | ||
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | |||
<!--Non–Guideline-Supported Use (Pediatric)--> | <!--Non–Guideline-Supported Use (Pediatric)--> | ||
|offLabelPedNoGuideSupport= | |offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | ||
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | |||
<!--Contraindications--> | <!--Contraindications--> | ||
Line 57: | Line 39: | ||
* CONTAINS ALCOHOL, IN CASE OF ACCIDENTAL OVERDOSE, CONSULT A POISON CONTROL CENTER IMMEDIATELY | * CONTAINS ALCOHOL, IN CASE OF ACCIDENTAL OVERDOSE, CONSULT A POISON CONTROL CENTER IMMEDIATELY | ||
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label. | |clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label. | ||
|postmarketing=[[nephrotoxicity]] and [[hypersensitivity]] | |||
|drugInteractions=<!--Use in Specific Populations--> | |||
|postmarketing=nephrotoxicity and hypersensitivity | |||
|drugInteractions= | |||
<!--Use in Specific Populations--> | |||
|useInPregnancyFDA=* '''Pregnancy Category''' | |useInPregnancyFDA=* '''Pregnancy Category''' | ||
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category''' | |useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category''' | ||
Line 79: | Line 58: | ||
<!--Administration and Monitoring--> | <!--Administration and Monitoring--> | ||
|administration=* Oral | |administration=* Oral | ||
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label. | |monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label. | ||
Line 89: | Line 66: | ||
<!--Overdosage--> | <!--Overdosage--> | ||
|overdose= | |overdose=There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label. | ||
There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label. | |||
<!--Pharmacology--> | <!--Pharmacology--> | ||
Line 97: | Line 72: | ||
<!--Drug box 2--> | <!--Drug box 2--> | ||
|drugBox=<!--Mechanism of Action--> | |drugBox=<!--Mechanism of Action--> | ||
|mechAction= | |mechAction=<!--Structure--> | ||
|structure=: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]] | |||
<!--Structure--> | |||
|structure= | |||
: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]] | |||
<!--Pharmacodynamics--> | <!--Pharmacodynamics--> |
Revision as of 21:05, 8 January 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Mercury (element) is a metal that is FDA approved for the treatment of FOR THE TEMPORARY RELIEF OF DIZZINESS,FEELING DISCOURAGED, DEPRESSION, PAINFUL DRYNESS OF THROAT. Common adverse reactions include hypersensitivity and nephrotoxicity.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
- FOR THE TEMPORARY RELIEF OF DIZZINESS,FEELING DISCOURAGED, DEPRESSION, PAINFUL DRYNESS OF THROAT.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Mercury (element) in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Mercury (element) in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding FDA-Labeled Use of Mercury (element) in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Mercury (element) in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Mercury (element) in pediatric patients.
Contraindications
There is limited information regarding Mercury (element) Contraindications in the drug label.
Warnings
- STOP USE AND CALL A DOCTOR IF SYMPTOMS PERSIST OR WORSEN. IF PREGNANT ORBREAST-FEEDING CONSULT A HEALTHCARE PROFESSIONAL BEFORE USE.
- CONTAINS ALCOHOL, IN CASE OF ACCIDENTAL OVERDOSE, CONSULT A POISON CONTROL CENTER IMMEDIATELY
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Mercury (element) in the drug label.
Postmarketing Experience
nephrotoxicity and hypersensitivity
Drug Interactions
There is limited information regarding Mercury (element) Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Mercury (element) in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Mercury (element) during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Mercury (element) with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Mercury (element) with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Mercury (element) with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Mercury (element) with respect to specific gender populations.
Race
There is no FDA guidance on the use of Mercury (element) with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Mercury (element) in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Mercury (element) in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Mercury (element) in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Mercury (element) in patients who are immunocompromised.
Administration and Monitoring
Administration
- Oral
Monitoring
There is limited information regarding Monitoring of Mercury (element) in the drug label.
IV Compatibility
There is limited information regarding IV Compatibility of Mercury (element) in the drug label.
Overdosage
There is limited information regarding Chronic Overdose of Mercury (element) in the drug label.
Pharmacology
There is limited information regarding Mercury (element) Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Mercury (element) Mechanism of Action in the drug label.
Structure
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Mercury (element) in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Mercury (element) in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Mercury (element) in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Mercury (element) in the drug label.
How Supplied
There is limited information regarding Mercury (element) How Supplied in the drug label.
Storage
- KEEP OUT OF REACH OF CHILDREN
Images
Drug Images
{{#ask: Page Name::Mercury (element) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Mercury (element) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
- DIRECTIONS: ORALLY 6 DROPS ORALLY, 4 TIMES A DAY.FOR AGES 2 TO ADULT
Precautions with Alcohol
- Alcohol-Mercury (element) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- TOTAL MERCURY ®[1]
Look-Alike Drug Names
- A® — B®[2]
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
- ↑ "TOTAL MERCURY- mercury liquid".
- ↑ "http://www.ismp.org". External link in
|title=
(help)
{{#subobject:
|Label Page=Mercury (element) |Label Name=Mercury 01.jpg
}}
{{#subobject:
|Label Page=Mercury (element) |Label Name=DailyMed - TOTAL MERCURY- mercury liquid .png
}}